ProfileGDS4459 / ENSG00000169783
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 45% 28% 25% 29% 19% 28% 24% 20% 22% 19% 30% 18% 16% 28% 17% 48% 18% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.2745
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.7128
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.2725
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.8329
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.0719
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.5828
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.2224
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.9920
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.0822
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.0319
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.630
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.8218
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.8316
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.7328
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.7917
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.3248
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.2818